Many peptides, when released as chemical messengers within the brain, have powerful influences on complex behaviours. Most strikingly, vasopressin and oxytocin, once thought of as circulating hormones whose actions were confined to peripheral organs, are now known to be released in the brain, where they have fundamentally important roles in social behaviours 1 . In humans, disruptions of these peptide systems have been linked to several neurobehavioural disorders, including Prader-Willi syndrome, affective disorders and obsessive-compulsive disorder, and polymorphisms of V1a vasopressin receptor have been linked to autism 2, 3 . Here we report that the rat olfactory bulb contains a large population of interneurons which express vasopressin, that blocking the actions of vasopressin in the olfactory bulb impairs the social recognition abilities of rats and that vasopressin agonists and antagonists can modulate the processing of information by olfactory bulb neurons. The findings indicate that social information is processed in part by a vasopressin system intrinsic to the olfactory system.
Complex social behaviour often depends on individual recognition, and most mammals distinguish individuals by their olfactory signatures. Some individuals are accorded a particular status, such as when a bond is formed between a mother and offspring, or between sexual partners in monogamous species. In these cases, an olfactory memory is forged in the olfactory bulb, partly as a result of the actions of peptides 4 . For example, oxytocin released in the mother's brain during parturition helps to establish the olfactory signatures of the offspring as memorable 5 .
The converse of social attachment is rejection of, or aggression towards, individuals who are recognized as intruders or competitors 6 . For this, vasopressin, a peptide closely related to oxytocin, is important through its actions at V1 receptors, and mice without functional accessory olfactory systems show many of the same behavioural deficits as mice that lack V1 receptors. This suggests that vasopressin is involved in the processing and/or integration of olfactory stimuli, and that it couples socially relevant olfactory cues to an appropriate behavioural response 7 .
We have identified a hitherto unreported population of vasopressin neurons in the olfactory bulb ( Fig. 1 ). We first saw these cells in a transgenic rat line in which enhanced green fluorescent protein (eGFP) was targeted to the vasopressin secretory pathway, resulting in its co-packaging with vasopressin in secretory vesicles 8 . The main olfactory bulb contains similar numbers of eGFP-expressing cells in males and females (99 6 14 and 103 6 10 cells per section, respectively; n 5 16 in each case), giving an estimated 5,000-7,000 neurons per bulb; the accessory bulbs contained ,1,000 neurons. These large ovoid neurons (,15 mm in diameter) are mostly located in the external plexiform layer close to the glomeruli (the structures in the bulb that directly receive inputs from olfactory receptor cells). Each has several large dendrites, one of which penetrates a single glomerulus, where it gives rise to many small branches. This suggests that the neurons receive direct inputs from olfactory nerve afferents. Other dendrites travel laterally to the external zones around neighbouring glomeruli ( Fig. 1a, b ). Using immunocytochemistry, we showed that these cells indeed synthesize vasopressin ( Fig. 1c, d) , and we confirmed their presence in wild-type rats (Fig. 1e ). We also confirmed that they express vasopressin messenger RNA, using in situ hybridization (Fig. 1f ), and that vasopressin is released from olfactory bulb explants in vitro in response to depolarization using K 1 in high concentration (release increased from 0.65 6 0.19 to 4.88 6 1.88 pg per sample; P , 0.01, n 5 9). The total bulb vasopressin content was 42.9 6 2.6 pg mg 21 wet weight (n 5 12; mixed sex).
Unlike periglomerular cells and short axon cells (two other cell populations in the same region), the vasopressin cells are immunonegative for GABA (c-aminobutyric acid), calretinin and calbindin-D28k ( Fig. 1g -i), but like external tufted cells 9,10 , they are immunoreactive for glutamate . No cells were immunoreactive for oxytocin. Whole-cell patch-clamp recordings from olfactory bulb slices showed that the vasopressin cells have electrophysiological characteristics like those of external tufted cells 10 . They show spontaneous bursts of action potentials (1.5 bursts per second) arising at the start of a slow depolarizing potential envelope (6.5 6 0.5 mV; n 5 5) that grows from a resting membrane potential of 255 6 2 mV, and have an input resistance of 189 6 38 MV. This bursting is voltage dependent (Fig. 1s ), and injection of depolarizing current converts bursts of action potentials to an irregular firing pattern.
Unlike most external tufted cells, most vasopressin cells do not project outside the olfactory bulb. Microinjections of the retrograde tracer Fluorogold into the cortical amygdala, the piriform cortex or the olfactory tubercle (major projection sites of olfactory bulb efferents 11 ) resulted in labelling of most mitral cells (the main output neurons) but no vasopressin cells ( Fig. 1m-o) , whereas injections into the anterior olfactory nucleus produced a very small number of labelled cells (data not shown). If the vasopressin cells do not project outside the olfactory bulb, any effects of the vasopressin that they release on olfactory information flow must be reflected by changes in the activity of other output cells. Vasopressin may be released from their axon terminals, but the dendrites may be a more important source as they are densely filled with vasopressin, and in the hypothalamus vasopressin is released from dendrites in both an activity-dependent manner and in an activity-independent way by agents that mobilize intracellular calcium 12 .
Vasopressin receptors are widespread in the main and accessory olfactory bulbs 13 . We found no immunoreactivity for V1a receptors on vasopressin cells, but some for V1b receptors ( Fig. 1p-r) , so vasopressin may act as an autocrine regulator through this receptor subtype 14 . Many other cells in the periglomerular region were immunoreactive for both subtypes, as were mitral cells in the main and accessory bulbs.
We tested the hypothesis that olfactory bulb vasopressin is involved in social recognition. It has already been shown that infusion of vasopressin into the bulb can enhance social recognition in rats. In those experiments, a peptide V1 receptor antagonist had no significant effect 15 . Here we used a non-peptide V1 receptor antagonist (OPC-21268) that diffuses more readily, and which is effective in antagonizing the actions of dendritically released vasopressin in the hypothalamus 16 . We injected the antagonist bilaterally into the olfactory bulb and tested social discrimination 17 . In this test, a juvenile rat is placed in the home cage of an adult male and the time that the adult spends investigating it is measured. Later, the same juvenile and an unfamiliar juvenile are introduced into the cage. Normally the adult investigates the familiar juvenile only briefly, and pays most attention to the unfamiliar juvenile; this memory is short lasting (,40 min) and is based on olfactory characteristics. In these experiments, we gave the adults a microinjection of the antagonist just before the juvenile was first presented. When retested, the adults did not discriminate between the familiar and unfamiliar juveniles, indicating that no memory of the juvenile was retained (analysis of variance: F(3, 39) 5 3.34, P 5 0.026; Fig. 2a , b).
To test involvement of the V1a receptor subtype specifically, we used infusions of a small interference RNA (siRNA) targeted against V1a receptor mRNA (siRNA has previously been used to silence gene expression successfully, including silencing the V2 receptor in mouse kidney 18 ); these infusions produced transfection in the olfactory bulb but not in the septum ( Supplementary Fig. 1 ). The effects of siRNA treatment were similar to those obtained with antagonist (treatment: F(1, 16) 5 17.86, P , 0.01; factor interaction: F(3, 48) 5 4.37, P , 0.01; Fig. 2c ). Control rats (but not siRNA-treated rats) could recognize juveniles by their complex individual olfactory fingerprint even in the presence of distracting monomolecular odours (Supplementary Fig. 2a ). Treatment with siRNA impaired habituation/ dishabituation to juvenile cues (control: F(4, 32) 5 3.42, P , 0.02; siRNA: F(4, 32) 5 0.47, P 5 0.76), but not to volatile odours (control: F(4, 32) 5 5.672, P , 0.01; siRNA: F(4, 32) 5 4.09, P , 0.01) or object recognition ( Fig. 3a-c) , and did not affect open-field behaviour ( Supplementary Fig. 2b, c) .
We also used a transgenic rat line in which the human diphtheria toxin receptor is inserted into the vasopressin promoter region. In these rats, infusion of diphtheria toxin 19, 20 results in a local, selective destruction of vasopressin cells. Transgenic rats pretreated with toxin infusions into the olfactory bulb showed a similar impairment of juvenile recognition (treatment: F(1, 29) 5 14.95, P , 0.01; factor interaction: F(1, 29) 5 4.99, P 5 0.033; Fig. 2d ), again with no impairment of object recognition (Fig. 3c) , locomotor activity or anxiety-related behaviours ( Supplementary Fig. 2d -i). Finally, we investigated vasopressin-dependent changes in olfactory bulb output. Current theories of glomerular function propose that olfactory nerve afferents activate external tufted cells, which activate short axon cells and periglomerular interneurons of the same glomerulus. This amplifies the olfactory nerve input and imposes on it a bursting pattern 10 , and this signal is transmitted to mitral cells. We recorded signals from mitral cells antidromically identified by electrical stimulation of the lateral olfactory tract in freely breathing, anaesthetized rats (Fig. 4a, b and Supplementary Fig. 3 ).
Under urethane anaesthesia, most mitral cells displayed patterned discharge comprising prolonged intermittent bursts of action potentials 21 (burst duration, 159 6 10 s; interburst time, 97 6 13 s; intraburst firing rate, 6.4 6 0.5 Hz; n 5 94; Supplementary Fig. 3 ). Within these bursts, the firing activity is modulated by the respiratory rhythm. In addition, many mitral cells (57 of 94) displayed a bimodal interspike interval distribution, reflecting the frequent occurrence of spike doublets within bursts. Thus, within bursts, these cells fired at two distinct instantaneous frequencies: at 100-250 Hz (doublets; mean modal interspike interval, 3.2 6 0.4 ms) and at ,50 Hz (mean modal interspike interval, 18 6 1 ms). The doublets are noteworthy as it is believed that only high-frequency firing episodes are backpropagated into the distal dendrites 22 . Topical administration of vasopressin or the V1 receptor antagonist onto the exposed bulb dorsal to the recording site modified the electrical activity of mitral cells. Vasopressin reduced the proportion of time they were active, and particularly reduced doublet firing, whereas the antagonist had the opposite effect (P , 0.05, paired t-tests; Fig. 4c-e ).
In 16 experiments, each involving a long recording from an identified mitral cell, we identified an odour to which that cell was particularly responsive, established the repeatability of that response in basal conditions and then retested the response to stimulation after topical application of vasopressin. In every case, the response to the odour was suppressed after vasopressin, whereas topical application of artificial cerebrospinal fluid had no effect on the responses of seven cells tested ( Fig. 4f-j) .
These findings suggest that vasopressin is a retrograde signal that filters activation of the mitral cells. Its effects may involve presynaptic modulation of noradrenaline or acetylcholine release, both of which are increased by retrodialysis of vasopressin in the olfactory bulbs of Figure 2 | Effects of V1a receptor blockade and vasopressin cell destruction on social recognition. a, A juvenile (J) is presented to an adult male (A) for 4 min. This juvenile is removed and after 30 or 180 min is represented together with a non-familiar juvenile, and the preference index (Methods Summary) is calculated. b, Administration of V1 receptor antagonist results in performance similar to that after extinction of shortterm discrimination (after 180 min). c, V1a receptor siRNA similarly impairs discrimination after 4, 8 and 16 d of treatment. d, Selective destruction of vasopressin cells by means of diphtheria toxin injection results in a similar impairment of discrimination in transgenic rats, but not in wild-type rats. Data shown, mean 1 s.e.m; *P , 0.05 and **P , 0.001 versus control; for each group, n is shown at the bottom of the corresponding column. NATURE | Vol 464 | 18 March 2010 LETTERS ewes 23 . Because this filtering is important for social recognition, it seems that the vasopressin release must depend on previous olfactory experience. In the hypothalamus, activity-dependent dendritic vasopressin release can be conditionally regulated ('primed') by recent experience 12, 24 ; such a mechanism in the olfactory bulb may therefore mediate conditional changes in olfactory recognition.
Thus, the olfactory bulb contains vasopressin cells that process olfactory signals relevant to social discrimination, and dendritic vasopressin release may be involved in filtering out familiar signals. Genetic variations in brain vasopressin signalling are associated with differences in social behaviours in humans 25, 26 as well as in animal models. We are not suggesting that social recognition in humans depends on olfactory signals; vasopressin affects social behaviour at many other sites as well as at the olfactory bulb 27, 28 , and in humans olfactory recognition probably has only a small role. However, these studies suggest a mechanism by which experience-dependent vasopressin release can facilitate social recognition, and this mechanism may be common to several sites of action.
METHODS SUMMARY
Animal experimental procedures were conducted with regulatory approval and ethics committee approvals in the UK, Germany and Japan.
We processed brains immunocytochemically to detect cells expressing vasopressin, GFP, calbindin-D28k, calretinin, GABA, glutamate and V1a and V1b receptors, and by in situ hybridization to detect vasopressin mRNA and eGFP mRNA. Eleven eGFP rats were stereotaxically microinjected with the retrograde tracer Fluorogold at various sites to detect cells projecting from the olfactory bulb. Vasopressin content and potassium-stimulated release from olfactory bulb explants was measured by radioimmune assay.
To test effects on social discrimination, we bilaterally infused the V1 receptor antagonist or vehicle into the olfactory bulbs of adult rats 15 . A juvenile was introduced into the adult's cage for 4 min and the duration of investigation by the adult was recorded; either 30 or 180 min later, the juvenile was reintroduced with another unfamiliar juvenile and the preference index ((time investigating unfamiliar juvenile)/(time investigating familiar juvenile 1 time investigating unfamiliar juvenile) 3 100) was measured 17 . Olfactory habituation and dishabituation 29 was tested by exposing rats to four 1-min trials separated by 10 min. During a fifth dishabituation trial, the rats were exposed to a novel stimulus. In rats injected with siRNA directed against V1a receptors (or control vectors), behaviours were tested 4, 8 and 16 d after injection.
For conditional ablation of vasopressin neurons, we used transgenic rats with a mutated human heparin-binding epidermal growth factor-like growth factor 30 gene (HBEGF) under the control of vasopressin promoter. Diphtheria toxin was microinjected into the olfactory bulb in rats anaesthetized with tribromoethanol.
In urethane-anaesthetized rats, electrical activity of mitral cells was recorded before and after administration of vasopressin or V1 receptor antagonist onto a small exposure of the bulb. Cells were tested with odours applied for 2 s in an air stream directed at the nose. For in vitro electrophysiology, whole-cell currentclamp recordings were made from GFP-expressing cells in 300-mm horizontal olfactory bulb slices.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
METHODS
Immunohistochemistry. Brains of eGFP and wild-type Sprague Dawley rats were perfusion fixed with 4% paraformaldehyde, post-fixed and cryoprotected 31 . Free-floating frozen bulb sections (52 mm) were immunostained with primary antibodies ( Supplementary Table 1 ) for 24 to 48 h at 4 uC. Immunoreactivity was visualized using either biotinylated secondary antibodies and Alexafluorophore-conjugated streptavidin or Alexa-fluorophore-conjugated secondary antibodies, at 1:500 for 2 h at room temperature (20 uC) . Sections were imaged as previously described 31 .
In situ hybridization. Six adult Wistar rats were decapitated under deep isoflurane anaesthesia. Brains were frozen at 240 uC in methylbutane and stored at 280 uC. Cryosections (16 mm) were thaw-mounted on RNA-free slides and stored at 280 uC. In situ hybridization was performed on sagittal sections using [ 35 S]-UTP-labelled ribonucleotide probes 32 . The pcDNA3 plasmid, containing vasopressin precursor cDNA (595-bp insert), was linearized with XbaI; the pBluescript KS plasmid, containing the vasopressin specific 39 end (230-bp insert) was linearized with HindIII. Both were in vitro transcribed with T7 RNA polymerase to yield an antisense complementary RNA probe. To generate an eGFP-specific riboprobe, the cDNA encoding GFP was subcloned into pBluescript SK. The eGFP fragment of peGFP-N3 (Clontech) was isolated using the BamHI and NotI sites and subcloned via the same sites into pBluescript SK. The construct was verified by sequencing. For the eGFP riboprobe, this plasmid was linearized with BamHI and in vitro transcribed with T3 polymerase. The specific activity of the probes was ,10 8 cpm mg 21 . The radioactivity was adjusted to 3.3 3 10 6 cpm per 100 ml hybridization buffer. The slides were dipped in Kodak NTB emulsion (Eastman Kodak) diluted 1:1 with 0.5% glycerol and exposed for 6 d at 4 uC, developed and counterstained 32 . Vasopressin release. Sprague Dawley rats (100-200 g) were decapitated and one half of an olfactory bulb was incubated in oxygenated ACSF. We applied 50 mM K 1 for 5 min and measured vasopressin in 5-min samples. The other half was sonicated (5 3 4 s) and centrifuged (10,000g, 5 min), and vasopressin content was determined in the supernatant by radioimmune assay (sensitivity, 0.1 pg; cross-reactivity to related peptides including oxytocin, ,0.7%; intra-and interassay variability, 6-9%). Antagonist, siRNA and diphtheria toxin injection and behaviour studies. The V1 receptor antagonist 33 (60 ng in 3 ml ACSF, OPC-21268; Otsuka America Pharmaceutical) or ACSF was infused under brief isoflurane anaesthesia over 2 min through bilateral guide cannulae (7 mm anterior to bregma and 1.3 mm lateral to midline, 3 mm deep, implanted 5 d earlier) as previously 15 . Rats received both vehicle and antagonist in a balanced crossover design. For object recognition tests 34 , rats were exposed to a laboratory glass bottle (Schott or Boro), a polyethylene terephthalate bottle (Nalgene) or a tube rack (W. Krannich) for 4 min. This was removed and 30 min later was reintroduced for 4 min with the other object (the preference index was calculated as in Methods Summary). For volatile scent habituation, a stainless-steel tea egg (50 mm 3 35 mm) hanging from the top of the cage and containing filter paper soaked with 5 ml carvone ((R)-(2)-carvone diluted 1:100 in diethylphtalat, Merck) was presented in trials 1-4. For dishabituation, the filter paper was soaked with 5 ml carvone mixed with isoamyl acetate. For juvenile habituation, the same juvenile was presented during trials 1-4 and a new juvenile was used during the dishabituation test. All behaviours were measured by experimenters blind to identity of treatment.
Social discrimination with an additional scent was tested by scenting the juvenile with carvone (5 ml; (R)-(2)-carvone diluted 1:100 in diethylphtalat, Merck) during the first session and with isoamyl acetate (5 ml, Sigma-Aldrich; diluted 1:100 in diethylphtalat) in the second session; the new juvenile was scented with carvone. Open-field behaviour was tested in two different laboratories using different equipment. In both cases, the rats were naive to the apparatus and the exposure duration was 10 min; exposure started with the rat placed in one corner of the apparatus. Behaviour was recorded using a video camera mounted over the open field and behaviour was scored. Rats (Sprague Dawley) that received the siRNA were placed in an open-field apparatus (100 cm 3 100 cm 3 50 cm) 19 d after treatment. Locomotor activity was scored by counting the number of crossed lines on a grid (10 cm 3 10 cm) on the floor of the open field. Anxiety-related behaviour was monitored by measuring how long the rat spent within the centre area (80 cm 3 80 cm), expressed as a percentage of the total duration of the openfield testing.
Transgenic rats (Lewis rats with a mutated HBEGF gene under the control of vasopressin promoter; see below) were tested 15-18 d after treatment with diphtheria toxin in an open-field apparatus measuring 60 cm 3 60 cm 3 40 cm. The total distance travelled and the time spent in the centre area (40 cm 3 40 cm) were recorded. The time spent in the centre area was expressed as a percentage of the total duration of testing. Transgenic rats were tested 16-19 d after treatment with diphtheria toxin in the elevated plus maze. The apparatus had two open arms (50 cm 3 10 cm) and two enclosed arms of the same size with 40-cm-high transparent walls (O'Hara & Co.). The arms and central square were constructed of black plastic and elevated to 65 cm. The rat was placed on the central platform with its head facing a closed arm. 35 . siRNA treatment. We used purified SMARTvector siRNA lentiviral particles targeting the rat vasopressin V1a receptor (NM053019, SH-092092-02-10) and SMARTvector empty vector control particles (S-004000-01), from Thermo Fisher Scientific. The titre of all solutions was .10 8 transforming units per millilitre. Lentiviral solution (2 ml) was infused through a fused silica capillary into each olfactory bulb. Behaviour was tested 4, 8 and 16 d later.
To confirm transfection by the SMARTvector lentiviral particles, the TurboGFP reporter protein (Thermo Fisher Scientific) was visualized immunohistochemically 20 d after injection. Rats were anaesthetized using a mixture of 0.1 ml Ketavet (Pharmacia) and 0.06 ml Dormitor (Bayer Vital), and transcardially perfused with physiological saline for 2 min and then 4% formaldehyde diluted in 0.1 M phosphate buffer (pH 7.4). Brains were post-fixed for 20 h in 4% formaldehyde diluted in phosphate buffer and transferred to 0.5 M sucrose in phosphate buffer for 6 h and to 1 M sucrose in phosphate buffer for ,40 h. Brains were shock-frozen in isopentanol at 250 uC and stored at 280 uC until cryosectioning. Floating frontal sections (25 mm) were incubated with anti-TurboGFP antibody (AB511, Evrogen; dilution, 1:10,000). Immunoreactive cells were visualized using the ABC-method using AxioVision software (version 4.7.1; Zeiss) and counterstained with Nissl staining. Immunostaining was observed in cells that surrounded the track of the injection cannula (data not shown) and in cells and fibres in the glomerular, external plexiform and mitral cell layers of the bulb. Conditional ablation of vasopressin neurons. We used transgenic Lewis rats with a mutated HBEGF gene under the control of vasopressin promoter 36 . The HBEGF mutant has a high affinity to diphtheria toxin but no EGF-like activity 30 . Diphtheria toxin binds to the extracellular domain of HBEGF, is incorporated into cells by receptor-mediated endocytosis, inactivates eukaryotic elongation factor 2 through ADP-ribosylation and thereby inhibits protein synthesis, leading to cell death 19 . Diphtheria toxin (D0564, Sigma-Aldrich; 300 pg per 3 ml) was microinjected bilaterally into the bulb of transgenic or wild-type rats anaesthetized with tribromoethanol (200 mg kg 21 intraperitoneal). Transgenic rats injected intracerebroventricularly with the toxin showed polyuria consistent with diabetes insipidus, but no polyuria was seen in rats after intrabulbar injections, indicating no significant loss of hypothalamic vasopressin cells (data not shown). Retrograde tracing. We stereotaxically microinjected eGFP rats under Hypnorm-Hypnovel anaesthesia (Janssen Pharmaceutica) with Fluorogold (Fluorochrome; 1 ml, 1%) into the cortical amygdala (22.1 mm posterior to bregma and 4 mm lateral to midline, 9.2 mm deep; n 5 3) 37 , anterior olfactory nucleus (3.2 mm anterior to bregma and 1.5 mm lateral to midline, 8 mm deep; n 5 2), piriform cortex (0.7 mm anterior to bregma and 4 mm lateral to midline, 8 mm deep; n 5 4) or olfactory tubercle (2.7 mm anterior to bregma and 2 mm lateral to midline, 8 mm deep; n 5 2) over 20 min. One week later, rats were perfused transcardially with 4% paraformaldehyde and brains were processed for immunohistochemistry. Electrophysiology. For in vitro electrophysiology, glass microelectrodes (8-12 MV) were filled with 134 mM K-gluconate, 4 mM MgCl 2 , 10mM HEPES, 3 mM Mg 2 ATP, 0.3 mM Tris-GTP, 4 mM NaCl and 0.2 mM EGTA (pH 7.3 adjusted with KOH, 270 mosM). In urethane-anaesthetized Sprague Dawley rats (250-300 g), extracellular recordings were made using glass microelectrodes filled with 0.9% NaCl (tip diameter, ,1 mm). Recordings were made from single mitral cells in the main olfactory bulb (,7 mm anterior to bregma and 1.3 mm lateral to midline) identified antidromically (collision test) by electrical stimulation of the ipsilateral lateral olfactory tract 21 (1.4 mm posterior to bregma and 3.2 mm lateral to midline, 9.5 mm deep, latencies in the range 1.0-5.8 ms) 37 . Activity quotients (ratio of time active and total time) were calculated, and the hazard function was plotted 38 (5-ms bins; hazard in bin [t, t 1 5 ms] equals number of intervals in bin [t, t 1 5 ms] divided by the number of intervals of length .t). Odours were applied through a polythene cannula (0.1-mm diameter) placed 3 mm in front of the nose. Cells were tested with a range of odours including heptanal, hexanal, lemon and peppermint, using a 1-ml syringe filled with odour-saturated air: 0.1 ml air was ejected over 2 s for each test; clean air had no effect. Statistics. Data were analysed by analysis of variance followed by Fisher's leastsignificant-difference test for planned comparisons, the Mann-Whitney U-test or unpaired Student's t-tests. P , 0.05 was considered significant.
